Cargando…
Recent advances in technology supporting biopharmaceutical production from mammalian cells
The demand for production of glycoproteins from mammalian cell culture continues with an increased number of approvals as biopharmaceuticals for the treatment of unmet medical needs. This is particularly the case for humanized monoclonal antibodies which are the largest and fastest growing class of...
Autores principales: | Butler, M., Meneses-Acosta, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080107/ https://www.ncbi.nlm.nih.gov/pubmed/23053101 http://dx.doi.org/10.1007/s00253-012-4451-z |
Ejemplares similares
-
Production of biopharmaceutical proteins by yeast: Advances through metabolic engineering
por: Nielsen, Jens
Publicado: (2013) -
Recent advances in developing molecular tools for targeted genome engineering of mammalian cells
por: Lim, Kwang-il
Publicado: (2015) -
Production of biofuels from C(1)
‐gases with Clostridium and related bacteria—Recent advances
por: Fernández‐Blanco, Carla, et al.
Publicado: (2023) -
Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals
por: Emami, Fakhrossadat, et al.
Publicado: (2022) -
Granulation techniques and technologies: recent progresses
por: Shanmugam, Srinivasan
Publicado: (2015)